Health
Medical researchers patented AIDS cure in 1990
By Juris Doctor Boyd Graves
Forward by Jerry Mazza
Online Journal Associate Editor
Jan 21, 2008, 00:18

I can�t think of any more fitting time than the anniversary of Dr. Martin Luther�s birthday to submit this article by Boyd Graves, an African American who has first-hand knowledge of AIDS and has sustained his life by his own research into viable cures. He has also persistently contributed to combating AIDS by submitting his findings to those in power to bring about �positive� changes in attitude towards cures at home and around the world.

As expected, he has been largely ignored, if not persistently harassed by elements in power. The below article is a perfect example, originally published on December 13, 2007, and forwarded with other materials by Dr. Graves to Speaker of the House Nancy Pilosi and Joe Leonard of the Congressional Black Caucus. In the name of Dr. King, let us assert one more time that We Shall Overcome, not just politically, but medically as well. Let there be life for our world, all of it. JM. . . .

In the Fall of 1990, two medical researchers, Drs. William Lyman and Steven Kaali, working at Albert Einstein College of Medicine in New York City made an important discovery. They found that they could inactivate the HIV virus by applying a low voltage direct current electrical potential with an extremely small current flow to AIDS infected blood in a test tube. Initially, they discovered this in the lab by inserting two platinum electrodes into a glass tube filled with HIV-1 (type 1) infected blood.

They applied a direct current to the electrodes and found that a current flow in the range of 50-100 microamperes (uA) produced the most effective results. Practically all of the HIV viral particles were adversely affected while normal blood cells remained unharmed. The viral particles were not directly destroyed by the electric current, but rather the outer protein coating of the virus was affected in such a way as to prevent the virus from producing reverse transcriptase, a necessary enzyme needed by the virus to invade human cells.

Reverse transcriptase allows the virus to enter a human T cell line (called CEM-SS) and commandeer the DNA reproduction machinery. After using the host cell to reproduce itself into thousands of new virii, the swollen host cell (now called syncytia or giant cell) will burst and spew the contents into the bloodstream or lymph system. This is how the virus spreads, but lacking reverse transcriptase, the HIV virus can't invade the host cell and it becomes vulnerable to destruction by the body's immune system. (The details of this experiment can be read from Kaali's patent application.)

A brief announcement of this discovery appeared in The Houston Post (Mar 20, 1991), then in Science News (Mar. 30, 1991 pg. 207) and later in Longevity magazine: (Dec.1992 pg. 14). Following their work in the Fall of 1990, Kaali and Lyman presented their findings at the First International Symposium on Combination Therapies (an AIDS conference) in Washington DC on March 14th, 1991. Kaali outlined two methods for treating an AIDS patient with this new therapy: One method involved removing a small amount of blood, electrifying it and then returning it to the patient's body. The second method involved sewing a miniature electrifying power supply along with two tiny electrodes directly into the lumen of an artery. For long term treatment, the mini electrifying unit needed to be removed and relocated to a new artery site after 30-45 days since scar tissue and calcification forming around the implant unit would lead to artery blockage. Kaali (along with co-inventor Peter Schwolsky) filed for a patent on this implantable electrifying device on Nov 16, 1990 and nine months later was granted patent #5,139,684 on August 18, 1992.

It's interesting to note two things here:

1. In order to obtain a patent from the United States Patent Office, Kaali and Schwolsky had to prove that the device works as claimed. Lacking solid proof, US patents are simply not granted.

2. Very often it takes years to obtain a patent, yet this patent was granted in only nine months; a further indication to me of the strength of their demonstrated claims

It's also interesting to note that other than the 3 publications mentioned above and the March '91 AIDS conference, nothing again appeared in print, radio, or TV about this important discovery as a potential treatment and cure for AIDS from Kaali and company. Most knowledgeable observers feel that Kaali and Lyman's discovery was intentionally suppressed following the March '91 AIDS conference presentation.

If AIDS research was on the level and not the sham that it actually is, this should have made front page news around the world. (Around 1999, I was contacted by a woman with AIDS who had managed to reach Dr. William Lyman over the phone. She asked him about his experiments with Kaali regarding blood electrification and if she could obtain the treatment through them. Lyman denied any knowledge of any AIDS treatment or cure. He said he never heard of Dr. Kaali and he had no idea what she was talking about concerning blood electrification and then hung up on her. What does that tell about the power of the people behind the suppression of this discovery?)

Accompanying document and addresses

Boyd Graves <boyded2003@yahoo.com> wrote:

They have no record of the U.S. Special Virus program (1962 - 1978). They have never mentioned the 1997 CURE for AIDS, "TETRASIL". WHY? Boyd EdGraves, J.D. 619-849-9364

Boyd Graves > wrote:

Date: Mon, 14 Jan 2008 14:14:52 -0800 (PST)

From: Boyd Graves boyded2003@yahoo.com

Subject: Africa and the U.S. AIDS CURE (patent#5676977)

To: Chairman Payne noel.lusane@mail.house.gov

CC: Speaker Nancy Pelosi wendell.primus@mail.house.gov

Senator Harry Reid carolyn_gluck@reid.senate.gov

Congressman BobFilner willie.blair@mail.house.gov. . . .

January 14, 2008

Donald Payne, Chairman

United States House Foreign Affairs Subcommittee on Africa and Global Health

United States Congress

United States of America

Re: Africa and the U.S. AIDS CURE

A Report to the United States House Foreign Affairs Subcommittee on Africa and Global Health

Dear Chairman Payne:

After contacting the Committee staff I hereby submit this request to provide testimony before Congress regarding my �Global Plan to End HIV/AIDS,� and the progress made to date.

During the year 2007, our efforts have led to the brink of clinical trials of the AIDS CURE in both Zambia and Angola. We seek the jurisdiction of the subcommittee for further oversight and direction.

In 1997, the United States patented the CURE for AIDS, U.S. patent#5676977. Go to www.uspto.gov. Part of the �Global Plan to end HIV/AIDS� is the initiation of �clinical trials� of the patented CURE for efficacy, protocol and modality. We believe this Congressional subcommittee is the appropriate Congressional authority to oversee the clinical trial testing of the ten year old patented CURE for AIDS.

Part two of the �PLAN� is a review and investigation of the U.S. Special Virus program (1962 � 1978). According to the experts, this federal program lies at the heart of the origin of HIV/AIDS. Specifically, the U.S. Special Virus program made the esp-1 virus in 1971. Under electron microscope, the esp-1 virus is identical to HIV. This point is further underscored when you compare the 1971 electron microscope of the esp-1 virus to the 2008 government HIV/AIDS poster, �Understanding HIV and AIDS.�

Mr. Chairman, how can the 2008 government poster of HIV/AIDS be identical to a photo from 1971? Further still, Congress funded the development of HIV/AIDS on June 9, 1969. See, U.S. House Resolution 15090, page 129.

The record reveals Congress funded the development of HIV/AIDS as early as May 1946. See, �Better� Than the Bomb, Time Magazine, June 3, 1946.

The record reveals that HIV/AIDS is a product of recombinant genetics, best highlighted by the �sheep� cells in its genome. The �visna� sheep cells alone PROVE HIV/AIDS is a synthetic biological agent EXACTLY as requested by the U.S. Pentagon on June 9, 1969. See, Science, Vol. 227, pp. 173 � 7, January 1985, see also, PROC NAS, Vol. 83, pp. 4007 � 11, June 1986, PROC NAS, Vol. 92, 3283 � 87, April 11, 1995.

According to the Proceedings of the United States of America, HIV/AIDS evolved from an �Icelandic� sheep disease! In fact the very strain is from 1932 (strain ks-1514). When we began giving syphilis to African Americans, we also began testing the infectious agent of HIV/AIDS on the sheep in Iceland. Tuskegee was not an isolated event!

In any testimony before your Committee we can conclude the evidence confirms HIV/AIDS is the result of a century long hunt for a contagious cancer that selectively kills. We also conclude the clinical trials of the patented CURE for AIDS should begin immediately as the health of Africa and the world begins the process of recovery from the greatest man made calamity in the history of the known world.

Respectfully submitted,

Boyd Ed Graves, J.D.
574 Garret Avenue
Chula Vista, CA 91910
619-849-9364
www.boydgraves.com
www.boydgraves.com/graves (bio)
www.boydgraves.com/comments/ (expert reviews)

cc: Nancy Pelosi, House Speaker

Joe Leonard, Congressional Black Caucus